BSEBoard Meeting29 Oct 2026 · 29 Oct 2026, 04:22 pm

Fortis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Un-audited financial results and other matters

Fortis Healthcare Ltd · 532843

✦ AI SummaryResults

Fortis Healthcare Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 05/11/2026 to consider and approve un-audited financial results and other matters.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Fortis Healthcare Ltd - 532843 - Board Meeting Intimation for Approval Of Un-Audited Financial Results And Other Matters

Attachments (1)

📄

b406f992-c291-4286-b99a-2c1aa1d193cc.pdf

pdf

Download →
View document text
Fortis Healthcare Limited Tower-A, Unitech Business Park, Block-F, South City 1, Sector – 41, Gurgaon, Haryana – 122 001 (India) Tel : 0124 492 1033 Fax : 0124 492 1041 Emergency : 105010 Email : secretarial@fortishealthcare.com Website : www.fortishealthcare.com October 29, 2026 FHL/SEC/2026-27 The National Stock Exchange of India Ltd. BSE Limited Scrip Symbol: FORTIS Scrip Code: 532843 Sub: Prior Intimation of Board Meeting under Regulation 29 and 50 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Madam/Sir, Pursuant to Regulation 29, 50 and other applicable regulations, if any, of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday, November 5, 2026, inter-alia, to consider and approve the following: (a) Un-audited financial results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30, 2026. (b) Alteration of rights of debenture holders and alteration in the terms of the debentures including the date of interest and matters affecting the rights and interests of debenture holders of the existing 1,55,000 (One lac and fifty-five thousand) listed, senior, unsecured, rated, redeemable Non-Convertible Debentures, each having a face value of INR 1,00,000/- (Indian Rupees One lac) and an aggregate value of up to INR 1550,00,00,000/- (Indian Rupees One Thousand Five Hundred and Fifty Crores only) Further, in continuation to our letter ref. FHL/SEC/2026-27 dated September 25, 2026 captioned “Closure of Trading Window”, it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till 48 hours from declaration of Un-audited Financial Results i.e. upto November 07, 2026. This is for your information and records. Thanking you, Yours Sincerely, For Fortis Healthcare Limited Satyendra Chauhan Company Secretary & Compliance Officer ICSI Membership: A14783 FORTIS HEALTHCARE LIMITED Regd. Office : Fortis Hospital, Sector 62, Phase – VIII, Mohali – 160062 Tel : 0172-4692222, Fax : 0172-5096221, CIN : L85110PB1996PLC045933